Efficacy and safety of dimethylfumarate in elderly psoriasis patients: a multicentric Italian study

Efficacy and safety of dimethylfumarate in elderly psoriasis patients: a multicentric Italian study

The number of psoriatic elderly patients is steadily increasing in the Western world, nevertheless they are frequently excluded from clinical trials and described as a high-risk group for adverse events. We conducted a retrospective multicentric study of DMF use in elderly (>65 years) psoriatic p...

Full description

Bibliographic Details
Main Authors:	Federica Ricceri, Federico Bardazzi, Gionata Buggiani, Martina Burlando, Elena Campione, Monica Corazza, Aldo Cuccia, Paolo Dapavo, Federica Filippi, Leonardo Zichichi, Aurora Parodi, Francesca Prignano
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-05-01
Series:	Journal of Dermatological Treatment
Subjects:	dimethylfumarate psoriasis elderly
Online Access:	http://dx.doi.org/10.1080/09546634.2021.1962000

Similar Items

Introducing a simplified titration scheme for dimethylfumarate (DMF) in patients with moderate-to-severe psoriasis: a case series
by: Ralph von Kiedrowski, et al.
Published: (2022-05-01)

Association of lymphopenia and eosinophilia with dimethylfumarate treatment efficacy and tolerability in psoriasis: a retrospective study
by: D.F.C van Hezik, et al.
Published: (2020-05-01)

[Tecfidera® (delayed-release dimethylfumarate) in the treatment of relapsing-remitting multiple sclerosis]
by: Lorenzo Giovanni Mantovani, et al.
Published: (2017-12-01)

Real-world use of dimehtyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus
by: Martina Burlando, et al.
Published: (2022-12-01)

Identification of galectin-1 and other cellular targets of alpha,beta-unsaturated carbonyl compounds, including dimethylfumarate, by use of click-chemistry probes
by: Max B. Sauerland, et al.
Published: (2023-02-01)

Activation of Nrf2/Keap1 pathway by oral Dimethylfumarate administration alleviates oxidative stress and age-associated infertility might be delayed in the mouse ovary
by: Nana Akino, et al.
Published: (2019-02-01)

Mapping the road to biologics in psoriasis and psoriatic arthritis: A nationwide drug utilization study
by: David Thein, et al.
Published: (2023-12-01)

Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study
by: Laura Gnesotto, et al.
Published: (2023-03-01)

Dimethylfumarate Inhibits Colorectal Carcinoma Cell Proliferation: Evidence for Cell Cycle Arrest, Apoptosis and Autophagy
by: Irina Kaluzki, et al.
Published: (2019-10-01)

The algorithm of treatment of the patient with relapsing-remitting multiple sclerosis with suboptimal response:the example of a clinical case
by: E. V. Popova, et al.
Published: (2018-05-01)

ORAL DRUGS FOR PATHOGENETIC TREATMENT OF MULTIPLE SCLEROSIS
by: E. V. Popova, et al.
Published: (2017-07-01)

Deferred time of delivery of biologic therapies in patients with stabilized psoriasis leads to a ‘perceived satisfaction’: a multicentric study
by: Ambra Di Altobrando, et al.
Published: (2022-01-01)

Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study
by: Francesco Bellinato, et al.
Published: (2023-03-01)

Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting
by: Martina Burlando, et al.
Published: (2021-05-01)

Severe Generalized Pustular Psoriasis Successfully Treated with Ixekizumab: A Case Report
by: Martina Burlando, et al.
Published: (2022-11-01)

Fumaric Acids Do Not Directly Influence Gene Expression of Neuroprotective Factors in Highly Purified Rodent Astrocytes
by: Kaweh Pars, et al.
Published: (2019-09-01)

Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice
by: Giovanna Casili, et al.
Published: (2020-02-01)

Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients
by: Martina Burlando, et al.
Published: (2021-10-01)

Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
by: Martina Burlando, et al.
Published: (2021-07-01)

Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single center study
by: Federica Ricceri, et al.
Published: (2022-05-01)

“De Novo” Psoriasis and Relapse of Psoriasis Induced by Dupilumab: Three New Cases and Review of the Literature
by: Ilaria Trave, et al.
Published: (2023-09-01)

Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: DIMESKIN-2, a Multicentre Single-Arm Phase IIIb Study
by: Giovanni Pellacani, et al.
Published: (2022-08-01)

Bulky Condyloma Acuminata following Ustekinumab Treatment for Plaque Psoriasis: A Case Report
by: Martina Burlando, et al.
Published: (2021-04-01)

Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)
by: Luigi Gargiulo, et al.
Published: (2023-08-01)

Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study—IL PSO (Italian landscape psoriasis)
by: Luigi Gargiulo, et al.
Published: (2023-07-01)

Synthesis and cellular evaluation of click-chemistry probes to study the biological effects of alpha, beta-unsaturated carbonyls
by: Chiara Morozzi, et al.
Published: (2022-06-01)

Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study
by: Gianluca Avallone, et al.
Published: (2023-02-01)

Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe Psoriasis
by: Francesca Prignano, et al.
Published: (2023-12-01)

Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient Wellbeing
by: Francesca Prignano, et al.
Published: (2022-05-01)

Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study
by: Riccardo G. Borroni, et al.
Published: (2021-11-01)

Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study
by: Andrea Chiricozzi, et al.
Published: (2020-07-01)

Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses – IL PSO (Italian landscape psoriasis)
by: Luigi Gargiulo, et al.
Published: (2024-01-01)

Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)
by: Andrea Chiricozzi, et al.
Published: (2023-12-01)

Ethosomal Gel for Topical Administration of Dimethyl Fumarate in the Treatment of HSV-1 Infections
by: Mariaconcetta Sicurella, et al.
Published: (2023-02-01)

Therapy of PsO in Special Subsets of Patients
by: Antonella Di Cesare, et al.
Published: (2022-11-01)

Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
by: Di Lernia V, et al.
Published: (2016-01-01)

Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement
by: Maria Concetta Fargnoli, et al.
Published: (2023-05-01)

Achievement and maintenance of therapeutic response to brodalumab in patients with moderate‐to‐severe plaque psoriasis: An Italian, observational, retrospective and prospective study (BRIGHT study)
by: Paolo Dapavo, et al.
Published: (2023-12-01)

Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice
by: Maria Esposito, et al.
Published: (2019-07-01)

New insight into the pathogenesis of nail psoriasis and overview of treatment strategies
by: Ventura A, et al.
Published: (2017-08-01)